Literature DB >> 22118181

Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.

W C Tan1, J Bourbeau, J M FitzGerald, R Cowie, K Chapman, P Hernandez, S A Buist, D D Sin.   

Abstract

OBJECTIVE: To measure the prevalence of chronic obstructive pulmonary disease (COPD) and determine the effect of age and sex on the variation in prevalence across major cities within the same country and health care system.
METHOD: We used the Burden of Obstructive Lung Disease (BOLD) methodology to estimate the prevalence of COPD in adults aged ≥ 40 years in different Canadian cities. The study used interviewer-administered questionnaires on respiratory, smoking and occupational history, medication use and comorbidities. Post-bronchodilator spirometry was used to classify subjects. We determined the prevalence and severity of COPD with and without adjustments for age and sex distribution across different cities.
RESULTS: The study population was 3042. Overall, 16.7% (95%CI 14.8-18.7) of study subjects met the criteria for Global Initiative for Chronic Obstructive Lung Disease (GOLD) severity Stage 1 or higher. The prevalence according to the criteria for the lower limits of normal of the ratio forced expiratory volume in 1 second/forced vital capacity was 11.6% (95%CI 9.9-13.3). COPD prevalence varied by severity across site (P = 0.0025). After age-sex adjustment, the variation disappeared (P> 0.16).
CONCLUSION: Age and sex differences account for most of the heterogeneity in COPD estimates across large cities within the same country. Adjustments for age and sex are essential in comparing COPD rates across the country.

Entities:  

Mesh:

Year:  2011        PMID: 22118181     DOI: 10.5588/ijtld.11.0211

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  15 in total

1.  Screening for undiagnosed obstructive airway disease: Does it make sense?

Authors:  Shawn Aaron
Journal:  Can Respir J       Date:  2015 Jul-Aug       Impact factor: 2.409

2.  Does nebulized fentanyl relieve dyspnea during exercise in healthy man?

Authors:  Houssam G Kotrach; Jean Bourbeau; Dennis Jensen
Journal:  J Appl Physiol (1985)       Date:  2015-03-12

3.  Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

Authors:  Wouter van Dijk; Wan Tan; Pei Li; Best Guo; Summer Li; Andrea Benedetti; Jean Bourbeau
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

4.  Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study.

Authors:  Wan C Tan; J Bourbeau; P Hernandez; K Chapman; R Cowie; M J FitzGerald; S Aaron; D D Marciniuk; F Maltais; D E O'Donnell; R Goldstein; D Sin
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

5.  Sleep Quality and Nocturnal Symptoms in a Community-Based COPD Cohort.

Authors:  Aditi Shah; Najib Ayas; Wan-Cheng Tan; Atul Malhotra; John Kimoff; Marta Kaminska; Shawn D Aaron; Rachel Jen
Journal:  COPD       Date:  2020-01-10       Impact factor: 2.409

Review 6.  Major care gaps in asthma, sleep and chronic obstructive pulmonary disease: a road map for knowledge translation.

Authors:  Louis-Philippe Boulet; Jean Bourbeau; Robert Skomro; Samir Gupta
Journal:  Can Respir J       Date:  2013 Jul-Aug       Impact factor: 2.409

7.  Absolute leukocyte telomere length in HIV-infected and uninfected individuals: evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease.

Authors:  Joseph C Y Liu; Janice M Leung; David A Ngan; Negar F Nashta; Silvia Guillemi; Marianne Harris; Viviane D Lima; Soo-Jung Um; Yuexin Li; Sheena Tam; Tawimas Shaipanich; Rekha Raju; Cameron Hague; Jonathon A Leipsic; Jean Bourbeau; Wan C Tan; P Richard Harrigan; Don D Sin; Julio Montaner; S F Paul Man
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  Incidence, Prevalence, and Mortality Trends in Chronic Obstructive Pulmonary Disease over 2001 to 2011: A Public Health Point of View of the Burden.

Authors:  Mariève Doucet; Louis Rochette; Denis Hamel
Journal:  Can Respir J       Date:  2016-07-11       Impact factor: 2.409

9.  Bronchodilator responsiveness and reported respiratory symptoms in an adult population.

Authors:  Wan C Tan; Jean Bourbeau; Paul Hernandez; Kenneth R Chapman; Robert Cowie; J Mark FitzGerald; Shawn Aaron; Darcy D Marciniuk; Francois Maltais; A Sonia Buist; Denis E O'Donnell; Don D Sin
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

10.  Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study.

Authors:  W C Tan; J Bourbeau; P Hernandez; K R Chapman; R Cowie; J M FitzGerald; D D Marciniuk; F Maltais; A S Buist; D E O'Donnell; D D Sin; S D Aaron
Journal:  Thorax       Date:  2014-04-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.